Both the Immunosuppressant SR31747 and the Antiestrogen Tamoxifen Bind to an Emopamil-Insensitive Site of Mammalian Δ8-Δ7 Sterol Isomerase
暂无分享,去创建一个
Pascual Ferrara | Raymond Paul | Pierre Casellas | P. Casellas | P. Ferrara | G. Fur | S. Silve | P. Dupuy | G. Loison | J. Rosenfeld | Gérard Loison | Gérard Le Fur | Sandra Silve | Nathalie De Nys | Pascal-Henry Dupuy | Christine Labit-Le Bouteiller | Jorge Rosenfeld | N. Nys | R. Paul | C. Bouteiller
[1] H. Glossmann,et al. The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. , 1997, Trends in pharmacological sciences.
[2] P Chambon,et al. Estradiol-inducible squelching and cell growth arrest by a chimeric VP16-estrogen receptor expressed in Saccharomyces cerevisiae: suppression by an allele of PDR1 , 1993, Molecular and cellular biology.
[3] M. Kaghad,et al. Emopamil-binding Protein, a Mammalian Protein That Binds a Series of Structurally Diverse Neuroprotective Agents, Exhibits Δ8-Δ7 Sterol Isomerase Activity in Yeast* , 1996, The Journal of Biological Chemistry.
[4] H. Glossmann,et al. Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors. , 1996, Biochemistry.
[5] H. Li,et al. Role of Multidrug Resistance P-glycoproteins in Cholesterol Biosynthesis (*) , 1996, The Journal of Biological Chemistry.
[6] P. Casellas,et al. Immunopharmacological profile of SR 31747: In vitro and in vivo studies on humoral and cellular responses , 1994, Journal of Neuroimmunology.
[7] P. Casellas,et al. In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747. , 1995, The Journal of pharmacology and experimental therapeutics.
[8] P. Casellas,et al. The sigma ligand SR 31747 prevents the development of acute graft-versus-host disease in mice by blocking IFN-gamma and GM-CSF mRNA expression. , 1995, International journal of immunopharmacology.
[9] J. Metherall,et al. Progesterone Inhibits Cholesterol Biosynthesis in Cultured Cells , 1996, The Journal of Biological Chemistry.
[10] J. Faye,et al. Antiestrogen specific, high affinity saturable binding sites in rat uterine cytosol. , 1980, Biochemical and biophysical research communications.
[11] P. Casellas,et al. Enhancement of endotoxin‐induced interleukin‐10 production by SR 31747A, a sigma ligand , 1995, European journal of immunology.
[12] E. Mercer,et al. Inhibition of sterol Δ8 → Δ7-isomerase and Δ14-reductase by fenpropimorph tridemorph and fenpropidin in cell-free enzyme systems from Saccharomyces cerevisiae , 1987 .
[13] S. Ng,et al. Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesis. , 1992, Journal of medicinal chemistry.
[14] J. Leysen,et al. Neuroprotective sigma ligands interfere with the glutamate‐activated NOS pathway in hippocampal cell culture , 1995, Synapse.
[15] M. Kołaczkowski,et al. Anticancer Drugs, Ionophoric Peptides, and Steroids as Substrates of the Yeast Multidrug Transporter Pdr5p* , 1996, The Journal of Biological Chemistry.
[16] M. Kaghad,et al. The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae , 1996, Molecular and cellular biology.
[17] S. Galiègue,et al. Purification and Characterization of the Human SR 31747A-binding Protein , 1997, The Journal of Biological Chemistry.
[18] B. Descomps,et al. Role of estrogen receptors and antiestrogen binding sites in an early effect of antiestrogens, the inhibition of cholesterol biosynthesis. , 1988, Journal of steroid biochemistry.
[19] P. Casellas,et al. Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747 , 1994, Journal of Neuroimmunology.
[20] F. Schuber,et al. Inhibition by the fungicide fenpropimorph of cholesterol biosynthesis in 3T3 fibroblasts. , 1988, The Biochemical journal.
[21] L. Murphy,et al. High-affinity anti-oestrogen binding site distinct from the oestrogen receptor , 1980, Nature.
[22] Gerald R. Fink,et al. Guide to yeast genetics and molecular biology , 1993 .
[23] F. Karst,et al. In vivo effects of fenpropimorph on the yeast Saccharomyces cerevisiae and determination of the molecular basis of the antifungal property , 1990, Antimicrobial Agents and Chemotherapy.
[24] L. Kangas,et al. Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] B. Katzenellenbogen,et al. Antiestrogen-binding sites distinct from the estrogen receptor: subecellular localization, ligand specificity, and distribution in tissues of the rat. , 1983, Endocrinology.
[26] H. Glossmann,et al. Phenylalkylamine Ca2+ Antagonist Binding Protein , 1995, The Journal of Biological Chemistry.